A detailed history of Blue Path Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 8,426 shares of MRK stock, worth $862,148. This represents 0.59% of its overall portfolio holdings.

Number of Shares
8,426
Previous 6,698 25.8%
Holding current value
$862,148
Previous $829 Million 15.4%
% of portfolio
0.59%
Previous 0.58%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$111.15 - $128.97 $192,067 - $222,860
1,728 Added 25.8%
8,426 $957 Million
Q2 2024

Aug 05, 2024

BUY
$123.8 - $132.96 $160,568 - $172,449
1,297 Added 24.01%
6,698 $829 Million
Q1 2024

Apr 19, 2024

BUY
$113.24 - $131.95 $106,445 - $124,032
940 Added 21.07%
5,401 $713 Million
Q4 2023

Jan 11, 2024

BUY
$100.18 - $109.02 $94,169 - $102,478
940 Added 26.7%
4,461 $530 Million
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $362,486 - $402,555
3,521 New
3,521 $363 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $259B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Blue Path Capital Management, LLC Portfolio

Follow Blue Path Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Path Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Path Capital Management, LLC with notifications on news.